UPDATED Jul 01, 2024
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CRDO | US$31.22 | 14.4% | 84.6% | US$5.3b | US$29.42 | PS26.7x | E60.9% | n/a | Semiconductors | ||
ADOC | €8.30 | 18.7% | 109.6% | €122.3m | €9.70 | PS20.2x | E104.5% | n/a | Pharmaceuticals & Biotech | ||
EH | US$14.12 | -0.2% | -13.8% | US$859.4m | US$24.98 | PS41.4x | E74.3% | n/a | Capital Goods | ||
A179900 | ₩30,600.00 | 5.2% | 59.0% | ₩484.1b | ₩60,000.00 | PS24.1x | E122.7% | 0% | Tech | ||
A067310 | ₩20,600.00 | 0.2% | -7.0% | ₩977.0b | ₩31,666.67 | PB3.3x | E96.3% | 0.2% | Semiconductors | ||
A178320 | ₩28,900.00 | 8.2% | 47.1% | ₩1.6t | ₩36,666.67 | PE149.6x | E48.1% | 0% | Tech | ||
4480 | JP¥3,505.00 | -2.4% | -36.2% | JP¥113.4b | JP¥5,800.00 | PE42.5x | E28.7% | n/a | Healthcare | ||
A204620 | ₩3,555.00 | -2.7% | -7.8% | ₩201.9b | ₩7,100.00 | PS1.9x | E72.4% | n/a | Commercial Services | ||
300181 | CN¥15.78 | 6.4% | 24.7% | CN¥11.2b | n/a | PE25.9x | E22.3% | 2.9% | Pharmaceuticals & Biotech | ||
688408 | CN¥89.64 | -4.8% | 7.6% | CN¥12.4b | CN¥89.23 | PE26.3x | E25.8% | 1.0% | Capital Goods | ||
GIG | NOK 29.20 | 2.5% | 16.8% | NOK 3.9b | NOK 45.03 | PE18.7x | E36.9% | n/a | Consumer Services | ||
PLT | AU$0.71 | -10.1% | 97.2% | AU$124.5m | AU$1.30 | PS1.7x | E106.4% | n/a | Diversified Financials | ||
VOW | NOK 6.58 | 11.9% | -51.5% | NOK 749.1m | NOK 11.00 | PB1.9x | E97.6% | 0% | Commercial Services | ||
CTT | AU$1.22 | 9.0% | -63.9% | AU$496.6m | AU$3.12 | PE23.9x | E26.7% | n/a | Retail | ||
A441270 | ₩9,230.00 | 5.7% | -1.7% | ₩341.3b | ₩11,500.00 | PE21.9x | E36.4% | n/a | Tech | ||
OSE | €6.14 | 3.7% | 77.7% | €133.6m | €7.15 | PS60x | E79.3% | n/a | Pharmaceuticals & Biotech | ||
HHR | AU$0.006 | -14.3% | -76.0% | AU$16.9m | n/a | PE5.7x | E86.3% | n/a | Energy | ||
CALTX | SEK 205.80 | 0.4% | 134.7% | SEK 11.0b | SEK 221.25 | PS8.4x | E52.9% | n/a | Pharmaceuticals & Biotech | ||
KEBNI B | SEK 1.58 | -2.3% | 29.0% | SEK 429.0m | SEK 2.20 | PS4.6x | E90.4% | n/a | Tech | ||
ACI | ₹728.10 | 5.6% | 35.4% | ₹89.8b | ₹757.20 | PE28.2x | E28.9% | 0.4% | Materials | ||
517522 | ₹585.95 | -0.7% | -29.4% | ₹29.7b | ₹772.00 | PE41.4x | E33.5% | 0.3% | Materials | ||
ATAT | US$18.67 | 2.4% | 3.0% | US$2.5b | US$27.17 | PE19.1x | E22.1% | 0.8% | Consumer Services | ||
PHC | UK£0.087 | 53.5% | -4.4% | UK£29.6m | n/a | PS3.3x | E121.3% | n/a | Materials | ||
GKP | UK£1.49 | -1.7% | 21.2% | UK£325.7m | UK£1.61 | PS3.3x | E47.6% | 0% | Energy |